Associated Papers
Novel fibrinogen mutations in pediatric patients: implications for neonatal coagulation screening and family genetic counseling.
Jiang J
Clinical Biochemistry, 2026
Novel and known fibrinogen gene mutations in Chinese pediatric patients with congenital dysfibrinogenemia: genetic and functional characterization.
Huang J et al.
Clinical Biochemistry, 2026
Clinical and Genetic Characterization of 51 Patients with Congenital Fibrinogen Disorders from China.
Cai Y et al.
Thrombosis and Haemostasis, 2025
Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia: case report.
El Beayni N et al.
Research and Practice in Thrombosis and Haemostasis, 2024
The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants.
Stefanucci L et al.
Blood, 2023
37647632 (PubMed )
Supplement: BLOOD_BLD-2023-020118-mmc3.xlsx › ST3.4
Congenital fibrinogen disorders: Strengthening genotype-phenotype correlations through novel genetic diagnostic tools.
Ramanan R et al.
British Journal of Haematology, 2023
Fibrin monomers derived from thrombogenic dysfibrinogenemia, Naples-type variant (BβAla68Thr), showed almost entirely normal polymerization.
Kamijo T et al.
Thrombosis Research, 2018
Clinical features and molecular basis of 102 Chinese patients with congenital dysfibrinogenemia.
Zhou J et al.
Blood Cells, Molecules & Diseases, 2015
Select a paper to view details